Randomized multicenter phase II trial of capecitabine versus S-1 as first-line treatment in elderly patients with advanced or recurrent unresectable gastric cancer
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2012
At a glance
- Drugs Capecitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 16 Feb 2010 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 16 Feb 2010 Actual patient numbers amended from 91 to 96 as reported by ClinicalTrials.gov.
- 01 Aug 2008 Primary endpoint 'objective clinical response rate' has been met.